Mutagenesis and Modeling of the Neurotensin Receptor NTR1: IDENTIFICATION OF RESIDUES THAT ARE CRITICAL FOR BINDING SR 48692, A NONPEPTIDE NEUROTENSIN ANTAGONIST
Open Access
- 26 June 1998
- journal article
- Published by Elsevier
- Vol. 273 (26) , 16351-16357
- https://doi.org/10.1074/jbc.273.26.16351
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Proposed Ligand Binding Site of the Transmembrane Receptor for Neurotensin(8–13)Published by Elsevier ,1996
- Molecular cloning of a levocabastine‐sensitive neurotensin binding siteFEBS Letters, 1996
- Neuropharmacological profile of non‐peptide neurotensin antagonistsFundamental & Clinical Pharmacology, 1995
- The Binding Site of Neuropeptide Vasopressin V1a ReceptorJournal of Biological Chemistry, 1995
- Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptorFEBS Letters, 1993
- Pharmacology of Nonpeptide Angiotensin II Receptor AntagonistsAnnual Review of Pharmacology and Toxicology, 1992
- Cholecystokinin AntagonistsAnnual Review of Pharmacology and Toxicology, 1991
- Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopyJournal of Molecular Biology, 1990
- Structure and functional expression of the cloned rat neurotensin receptorNeuron, 1990
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973